大参林

About 大参林

Founded in 1999 and headquartered in Guangzhou, China, Dashenlin Pharmaceutical Group Co., Ltd. has grown into one of China’s most influential pharmaceutical retail chains. The Group operates across 21 provinces and municipalities, with over 16,000 retail outlets and approximately 50,000 employees, including nearly 20,000 pharmaceutical professionals. Ranked No.1 in China’s pharmacy retail industry by both revenue and store count, Dashenlin has consistently been recognized among the “Top 500 Service Enterprises in China” and the “Top 100 Chain Pharmacies in China.” As of 2024, the Group recorded annual revenue of approximately RMB 28.7 billion, maintaining a leading position through its strong capabilities in scale, digitalization, supply chain management, in-house distribution systems, branding, and talent development. As part of the Group’s international expansion, PT Dashenlin Pharma Indonesia brings this proven retail healthcare model and world-class pharmaceutical expertise to the Indonesian market—integrating pharmaceutical manufacturing, wholesale, and retail under one ecosystem. We offer a comprehensive range of products including prescription and over-the-counter medicines, Chinese and Western patent medicines, herbal remedies, health supplements, medical devices, and cosmetic health products. Committed to improving access to quality healthcare, PT Dashenlin Pharma Indonesia is dedicated to serving the health and well-being of communities across Indonesia.